https://finwires.com/en/article/acceleware-enters-second-farm-in-agreement-saskatchewan-6657859 FINWIRES en 2026-04-29T16:46:10.000Z Acceleware Enters into Second Farm-In Agreement in Saskatchewan Mannville https://finwires.com/en/article/general-dynamics-raises-full-year-earnings-outlook-after-6657857 FINWIRES en 2026-04-29T16:45:45.000Z General Dynamics Raises Full-Year Earnings Outlook After First-Quarter Beat; Shares Jump https://finwires.com/en/article/research-alert-cfra-downgrades-opinion-shares-nucor-6657858 FINWIRES en 2026-04-29T16:45:11.000Z Research Alert: CFRA Downgrades Opinion On Shares Of Nucor Corporation To Sell From Hold https://finwires.com/en/article/da-davidson-cuts-domino-s-pizza-price-target-423-436-6657850 FINWIRES en 2026-04-29T16:44:04.000Z DA Davidson Cuts Domino's Pizza Price Target to $423 From $436, Maintains Buy Rating https://finwires.com/en/article/wells-fargo-adjusts-stanley-black-decker-price-target-80-75-6657844 FINWIRES en 2026-04-29T16:42:35.000Z Wells Fargo Adjusts Stanley Black & Decker Price Target to $80 From $75, Maintains Equal Weight Rating https://finwires.com/en/article/btig-cuts-price-target-ge-healthcare-technologies-80-85-6657839 FINWIRES en 2026-04-29T16:42:06.000Z BTIG Cuts Price Target on GE Healthcare Technologies to $80 From $85, Maintains Buy Rating https://finwires.com/en/article/wedbush-raises-marcus-price-target-23-22-maintains-6657835 FINWIRES en 2026-04-29T16:41:51.000Z Wedbush Raises Marcus Price Target to $23 From $22, Maintains Outperform Rating https://finwires.com/en/article/market-chatter-trump-says-us-maintain-naval-blockade-iran-6657831 FINWIRES en 2026-04-29T16:40:15.000Z Market Chatter: Trump Says US Will Maintain Naval Blockade on Iran Until Nuclear Deal https://finwires.com/en/article/redeia-flags-1-75-billion-2026-investment-interconnection-6657826 FINWIRES en 2026-04-29T16:40:02.000Z Redeia Flags $1.75 Billion 2026 Investment as Interconnection Projects Move Forward https://finwires.com/en/article/ing-notes-dovish-leaning-hold-bank-canada-6657820 FINWIRES en 2026-04-29T16:36:48.000Z ING Notes A Dovish-Leaning Hold by The Bank of Canada https://finwires.com/en/article/ollie-s-bargain-outlet-s-relative-comp-softness-q1-likely-6657814 FINWIRES en 2026-04-29T16:34:12.000Z Ollie's Bargain Outlet's Relative Comp Softness in Q1 Likely due to Weather, RBC Says https://finwires.com/en/article/booking-holdings-middle-east-impact-seen-easing-march-6657808 FINWIRES en 2026-04-29T16:32:33.000Z Booking Holdings Middle East Impact Seen Easing From March Levels, RBC Says https://finwires.com/en/article/bank-canada-still-looking-through-inflation-staying-nimble-6657809 FINWIRES en 2026-04-29T16:32:19.000Z Bank of Canada Is Still Looking Through Inflation, But Is Staying "Nimble", Says National Bank https://finwires.com/en/article/update-mizuho-keeps-price-target-immix-biopharma-15-6657799 FINWIRES en 2026-04-29T16:30:19.000Z Update: Mizuho Keeps Price Target on Immix Biopharma to $15, Maintains Outperform Rating https://finwires.com/en/article/bloom-energy-fuel-cell-demand-driven-time-power-grid-6657797 FINWIRES en 2026-04-29T16:30:15.000Z Bloom Energy Fuel Cell Demand Driven by Time to Power, Grid Constraints, Water Scarcity, RBC Says https://finwires.com/en/article/us-oil-gas-reserves-fall-alaska-gains-new-projects-eia-says-6657790 FINWIRES en 2026-04-29T16:30:04.000Z US Oil, Gas Reserves Fall as Alaska Gains on New Projects, EIA Says https://finwires.com/en/article/update-mizuho-keeps-price-target-ideaya-biosciences-52-6657788 FINWIRES en 2026-04-29T16:30:02.000Z Update: Mizuho Keeps Price Target on IDEAYA Biosciences to $52, Maintains Outperform Rating https://finwires.com/en/article/update-mizuho-securities-keeps-price-target-apellis-6657784 FINWIRES en 2026-04-29T16:29:44.000Z Update: Mizuho Securities Keeps Price Target on Apellis Pharmaceuticals to $41, Maintains Neutral Rating https://finwires.com/en/article/starbucks-faces-margin-risks-despite-strong-start-rbc-says-6657780 FINWIRES en 2026-04-29T16:29:30.000Z Starbucks Faces Margin Risks Despite Strong Start, RBC says https://finwires.com/en/article/update-mizuho-securities-keeps-terns-pharmaceuticals-6657774 FINWIRES en 2026-04-29T16:29:28.000Z Update: Mizuho Securities Keeps Terns Pharmaceuticals to Neutral, Price Target to $53 https://finwires.com/en/article/montage-gold-completes-c-410-7-million-acquisition-african-6657773 FINWIRES en 2026-04-29T16:29:18.000Z Montage Gold Completes Its C$410.7-Million Acquisition of African Gold https://finwires.com/en/article/update-mizuho-securities-keeps-price-target-harmony-6657766 FINWIRES en 2026-04-29T16:28:41.000Z Update: Mizuho Securities Keeps Price Target on Harmony Biosciences to $50, Maintains Outperform Rating https://finwires.com/en/article/update-mizuho-securities-keeps-verastem-price-target-16-6657765 FINWIRES en 2026-04-29T16:28:24.000Z Update: Mizuho Securities Keeps Verastem Price Target to $16, Maintains Outperform Rating https://finwires.com/en/article/update-mizuho-keept-price-target-corbus-pharmaceuticals-40-6657760 FINWIRES en 2026-04-29T16:28:09.000Z Update: Mizuho Keept Price Target on Corbus Pharmaceuticals to $40, Maintains Outperform Rating https://finwires.com/en/article/update-mizuho-keeps-price-target-axsome-therapeutics-228-6657756 FINWIRES en 2026-04-29T16:27:44.000Z Update: Mizuho Keeps Price Target on Axsome Therapeutics to $228, Maintains Outperform Rating https://finwires.com/en/article/west-pharmaceutical-services-insider-sold-shares-worth-859-6657753 FINWIRES en 2026-04-29T16:27:29.000Z West Pharmaceutical Services Insider Sold Shares Worth $859,753, According to a Recent SEC Filing https://finwires.com/en/article/colgate-palmolive-set-report-in-line-q1-reaffirm-guidance-6657749 FINWIRES en 2026-04-29T16:27:21.000Z Colgate-Palmolive Set to Report In-line Q1, Reaffirm Guidance Amid Cost Headwinds, RBC Says https://finwires.com/en/article/research-alert-cfra-raises-rating-shares-garmin-ltd-hold-6657747 FINWIRES en 2026-04-29T16:25:11.000Z Research Alert: CFRA Raises Rating On Shares Of Garmin Ltd. To Hold From Sell https://finwires.com/en/article/planet-fitness-enters-q1-earnings-under-pressure-amid-weak-6657739 FINWIRES en 2026-04-29T16:22:36.000Z Planet Fitness Enters Q1 Earnings Under Pressure Amid Weak Trends, Macro Uncertainty, RBC Says https://finwires.com/en/article/bp-s-q1-oil-trading-outperformance-makes-up-upstream-6657732 FINWIRES en 2026-04-29T16:20:17.000Z BP's Q1 Oil-Trading Outperformance Makes Up for Upstream Shortfall, RBC Says https://finwires.com/en/article/evercore-isi-adjusts-price-target-sherwin-williams-390-400-6657722 FINWIRES en 2026-04-29T16:19:40.000Z Evercore ISI Adjusts Price Target on Sherwin-Williams to $390 From $400, Maintains Outperform Rating https://finwires.com/en/article/estee-lauder-q3-likely-slightly-below-consensus-rbc-says-6657719 FINWIRES en 2026-04-29T16:19:22.000Z Estee Lauder Q3 Likely to be Slightly Below Consensus, RBC Says https://finwires.com/en/article/tsx-down-230-points-midday-info-tech-industrials-worst-6657713 FINWIRES en 2026-04-29T16:19:16.000Z TSX Down 230 Points at Midday With Info Tech, Industrials, The Worst Performers https://finwires.com/en/article/mizuho-adjusts-price-target-immix-biopharma-15-10-maintains-6657712 FINWIRES en 2026-04-29T16:18:40.000Z Mizuho Adjusts Price Target on Immix Biopharma to $15 From $10, Maintains Outperform Rating https://finwires.com/en/article/mizuho-adjusts-price-target-ideaya-biosciences-52-46-6657710 FINWIRES en 2026-04-29T16:18:27.000Z Mizuho Adjusts Price Target on IDEAYA Biosciences to $52 From $46, Maintains Outperform Rating https://finwires.com/en/article/mizuho-securities-raises-price-target-apellis-6657706 FINWIRES en 2026-04-29T16:15:56.000Z Mizuho Securities Raises Price Target on Apellis Pharmaceuticals to $41 From $20, Maintains Neutral Rating https://finwires.com/en/article/mizuho-securities-downgrades-terns-pharmaceuticals-neutral-6657698 FINWIRES en 2026-04-29T16:15:31.000Z Mizuho Securities Downgrades Terns Pharmaceuticals to Neutral From Outperform, Trims Price Target to $53 From $54 https://finwires.com/en/article/research-alert-cfra-reiterates-buy-opinion-shares-booking-6657692 FINWIRES en 2026-04-29T16:15:10.000Z Research Alert: CFRA Reiterates Buy Opinion On Shares Of Booking Holdings Inc. https://finwires.com/en/article/mizuho-securities-cuts-price-target-harmony-biosciences-50-6657691 FINWIRES en 2026-04-29T16:14:55.000Z Mizuho Securities Cuts Price Target on Harmony Biosciences to $50 From $46, Maintains Outperform Rating https://finwires.com/en/article/mizuho-securities-adjusts-verastem-price-target-16-18-6657684 FINWIRES en 2026-04-29T16:14:38.000Z Mizuho Securities Adjusts Verastem Price Target to $16 From $18, Maintains Outperform Rating https://finwires.com/en/article/mizuho-adjusts-price-target-corbus-pharmaceuticals-40-39-6657680 FINWIRES en 2026-04-29T16:14:25.000Z Mizuho Adjusts Price Target on Corbus Pharmaceuticals to $40 From $39, Maintains Outperform Rating https://finwires.com/en/article/mizuho-adjusts-price-target-axsome-therapeutics-228-230-6657678 FINWIRES en 2026-04-29T16:14:11.000Z Mizuho Adjusts Price Target on Axsome Therapeutics to $228 From $230, Maintains Outperform Rating https://finwires.com/en/article/mizuho-lifts-price-target-amylyx-pharmaceuticals-21-19-6657668 FINWIRES en 2026-04-29T16:12:42.000Z Mizuho Lifts Price Target on Amylyx Pharmaceuticals to $21 From $19, Maintains Outperform Rating https://finwires.com/en/article/dynatrace-well-positioned-growth-strategy-amid-starboard-6657661 FINWIRES en 2026-04-29T16:11:59.000Z Dynatrace Well Positioned on Growth Strategy Amid Starboard Activist Push, Wedbush Says https://finwires.com/en/article/trump-rejects-iran-s-offer-orders-blockade-until-nuclear-6657660 FINWIRES en 2026-04-29T16:11:29.000Z Trump Rejects Iran's Offer, Orders Blockade Until Nuclear Deal, Axios Reports https://finwires.com/en/article/palantir-technologies-could-see-lower-contract-values-q1-6657654 FINWIRES en 2026-04-29T16:10:48.000Z Palantir Technologies Could See Lower Contract Values in Q1, RBC Says https://finwires.com/en/article/market-chatter-united-airlines-wary-pursuing-smaller-6657652 FINWIRES en 2026-04-29T16:10:42.000Z Market Chatter: United Airlines Wary of Pursuing Smaller Acquisitions Like JetBlue https://finwires.com/en/article/research-alert-psx-derivative-headwinds-q1-beat-nonetheless-6657648 FINWIRES en 2026-04-29T16:10:10.000Z Research Alert: Psx: Derivative Headwinds, But A Q1 Beat Nonetheless https://finwires.com/en/article/stifel-canada-previews-colliers-international-s-q1-results-6657640 FINWIRES en 2026-04-29T16:07:18.000Z Stifel Canada Previews Colliers International's Q1 Results https://finwires.com/en/article/research-alert-cfra-retains-buy-rating-shares-abbvie-inc-6657631 FINWIRES en 2026-04-29T16:05:10.000Z Research Alert: CFRA Retains Buy Rating On Shares Of Abbvie Inc.